PAPER Johnson SC, La Rue A, Hermann BP, Xu G, Koscik RL, Jonaitis EM, Bendlin BB, Hogan KJ, Roses AD, Saunders AM, Lutz MW, Asthana S, Green RC, Sager MA
SEARCH RESULTS
330986 RESULTS
PAPER Jack CR, Barkhof F, Bernstein MA, Cantillon M, Cole PE, Decarli C, Dubois B, Duchesne S, Fox NC, Frisoni GB, Hampel H, Hill DL, Johnson K, Mangin JF, Scheltens P, Schwarz AJ, Sperling R, Suhy J, Thompson PM, Weiner M, Foster NL
Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease.
Alzheimers Dement. 2011 Jul;7(4):474-485.e4. PubMed: 21784356PAPER Hornberger M, Geng J, Hodges JR
Convergent grey and white matter evidence of orbitofrontal cortex changes related to disinhibition in behavioural variant frontotemporal dementia.
Brain. 2011 Sep;134(Pt 9):2502-12. PubMed: 21785117PAPER Cornejo A, Jiménez JM, Caballero L, Melo F, Maccioni RB
Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease.
J Alzheimers Dis. 2011 Jan 1;27(1):143-53. PubMed: 21785188PAPER David R, Friedman L, Mulin E, Noda A, Le Duff F, Kennedy Q, Garcia R, Robert PH, Yesavage JA, Zeitzer JM,
Lack of Association Between COMT Polymorphisms and Apathy in Alzheimer's Disease.
J Alzheimers Dis. 2011 Jan 1;27(1):155-61. PubMed: 21785189PAPER Facecchia K, Fochesato LA, Ray SD, Stohs SJ, Pandey S
Oxidative toxicity in neurodegenerative diseases: role of mitochondrial dysfunction and therapeutic strategies.
J Toxicol. 2011;2011:683728. PubMed: 21785590PAPER Atkins ER, Panegyres PK
The clinical utility of gene testing for Alzheimer's disease.
Neurol Int. 2011 Jun;3(1):e1. PubMed: 21785673PAPER Shibata N, Ohnuma T, Kuerban B, Komatsu M, Baba H, Arai H
Genetic Association between Akt1 Polymorphisms and Alzheimer's Disease in a Japanese Population.
Int J Alzheimers Dis. 2011;2011:762471. PubMed: 21785701PAPER Modarresi F, Faghihi MA, Patel NS, Sahagan BG, Wahlestedt C, Lopez-Toledano MA
Knockdown of BACE1-AS Nonprotein-Coding Transcript Modulates Beta-Amyloid-Related Hippocampal Neurogenesis.
Int J Alzheimers Dis. 2011;2011:929042. PubMed: 21785702PAPER Fortress AM, Buhusi M, Helke KL, Granholm AC
Cholinergic Degeneration and Alterations in the TrkA and p75NTR Balance as a Result of Pro-NGF Injection into Aged Rats.
J Aging Res. 2011;2011:460543. PubMed: 21785728PAPER Alexopoulos P, Sorg C, Förschler A, Grimmer T, Skokou M, Wohlschläger A, Perneczky R, Zimmer C, Kurz A, Preibisch C
Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer's disease measured by pulsed arterial spin labeling MRI.
Eur Arch Psychiatry Clin Neurosci. 2011 Jul 24; PubMed: 21786091PAPER Müller M, Cárdenas C, Mei L, Cheung KH, Foskett JK
Constitutive cAMP response element binding protein (CREB) activation by Alzheimer's disease presenilin-driven inositol trisphosphate receptor (InsP3R) Ca2+ signaling.
Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13293-8. PubMed: 21784978PAPER Chakroborty S, Stutzmann GE
Early calcium dysregulation in Alzheimer's disease: setting the stage for synaptic dysfunction.
Sci China Life Sci. 2011 Aug;54(8):752-62. PubMed: 21786198PAPER Sperling RA, Jack CR, Black SE, Frosch MP, Greenberg SM, Hyman BT, Scheltens P, Carrillo MC, Thies W, Bednar MM, Black RS, Brashear HR, Grundman M, Siemers ER, Feldman HH, Schindler RJ
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup.
Alzheimers Dement. 2011 Jul;7(4):367-85. PubMed: 21784348PAPER Gustavsson A, Cattelin F, Jönsson L
Costs of care in a mild-to-moderate Alzheimer clinical trial sample: key resources and their determinants.
Alzheimers Dement. 2011 Jul;7(4):466-73. PubMed: 21784355Current Filters
No filters selected